• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本 COVID-19 第 1、2 和 3 波患者的临床特征和住院死亡率的时间趋势:一项回顾性队列研究。

Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study.

机构信息

Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Tokyo, Japan.

Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Tokyo, Japan; Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.

出版信息

J Infect Chemother. 2022 Oct;28(10):1393-1401. doi: 10.1016/j.jiac.2022.06.013. Epub 2022 Jun 29.

DOI:10.1016/j.jiac.2022.06.013
PMID:35779801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9239980/
Abstract

INTRODUCTION

Little information is available on the temporal trends in the clinical epidemiology and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) in Japan for waves 1, 2, and 3.

METHODS

A national claims database was used to analyze the time trends in admission, medical procedure, and in-hospital mortality characteristics among patients with COVID-19. Patients who were ≥18 years and discharged from January 1, 2020 to February 28, 2021 were included.

RESULTS

A multilevel logistic regression analysis of 51,252 patients revealed a decline in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.17-4.07%; relative risk reduction = 23-59%; reference month of April 2020 = 5.32%). In the subgroup analysis, a decline in mortality was also observed in patients requiring oxygen support but not mechanical ventilation (risk-adjusted mortality range = 5.98-11.68%; relative risk reduction = 22-60%; reference month of April 2020 = 15.06%). Further adjustments for medical procedure changes in the entire study population revealed a decrease in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.66-4.05%; relative risk reduction = 24-50%).

CONCLUSIONS

A decline in in-hospital mortality was observed in waves 2 and 3 after adjusting for patient/hospital-level characteristics and medical treatments. The reasons for this decline warrant further research to improve the outcomes of hospitalized patients.

摘要

简介

关于日本第 1、2 和 3 波 COVID-19 患者的临床流行病学和住院死亡率的时间趋势,信息有限。

方法

使用国家索赔数据库分析了 COVID-19 患者入院、医疗程序和住院死亡率特征的时间趋势。纳入年龄≥18 岁且于 2020 年 1 月 1 日至 2021 年 2 月 28 日出院的患者。

结果

对 51252 例患者进行的多水平逻辑回归分析显示,第 2 和第 3 波的死亡率下降(风险调整死亡率范围为 2.17-4.07%;相对风险降低 23-59%;参考月为 2020 年 4 月 5.32%)。在亚组分析中,需要氧疗但不需要机械通气的患者的死亡率也有所下降(风险调整死亡率范围为 5.98-11.68%;相对风险降低 22-60%;参考月为 2020 年 4 月 15.06%)。对整个研究人群的医疗程序变化进行进一步调整后,第 2 和第 3 波的死亡率下降(风险调整死亡率范围为 2.66-4.05%;相对风险降低 24-50%)。

结论

在调整了患者/医院水平特征和治疗方法后,第 2 和第 3 波的住院死亡率下降。这种下降的原因需要进一步研究,以改善住院患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948a/9239980/884dc33ce3e0/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948a/9239980/01f281d877d4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948a/9239980/70ef9981bd13/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948a/9239980/884dc33ce3e0/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948a/9239980/01f281d877d4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948a/9239980/70ef9981bd13/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948a/9239980/884dc33ce3e0/gr3_lrg.jpg

相似文献

1
Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study.日本 COVID-19 第 1、2 和 3 波患者的临床特征和住院死亡率的时间趋势:一项回顾性队列研究。
J Infect Chemother. 2022 Oct;28(10):1393-1401. doi: 10.1016/j.jiac.2022.06.013. Epub 2022 Jun 29.
2
Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study.瑞士 COVID-19 相关住院死亡率和人口统计学的时间趋势-一项回顾性单中心队列研究。
Swiss Med Wkly. 2021 Jul 19;151:w20572. doi: 10.4414/smw.2021.20572.
3
Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force.第一至第五波感染期间 COVID-19 住院患者的特征:日本 COVID-19 工作组的报告。
BMC Infect Dis. 2022 Dec 12;22(1):935. doi: 10.1186/s12879-022-07927-w.
4
Mortality-associated Risk Factors in Hospitalized COVID-19 Patients in Japan: Findings of the CLOT-COVID Study.日本住院 COVID-19 患者死亡相关危险因素:CLOT-COVID 研究结果。
J Epidemiol. 2023 Mar 5;33(3):150-157. doi: 10.2188/jea.JE20220201. Epub 2022 Dec 23.
5
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic.美国在 COVID-19 大流行期间患者特征和 COVID-19 院内死亡率的趋势。
JAMA Netw Open. 2021 May 3;4(5):e218828. doi: 10.1001/jamanetworkopen.2021.8828.
8
Serious mental illness and in-hospital mortality among hospitalized patients with acute COVID-19: A large-database analysis in Japan.急性 COVID-19 住院患者的严重精神疾病与院内死亡率:日本大型数据库分析。
Gen Hosp Psychiatry. 2023 May-Jun;82:1-6. doi: 10.1016/j.genhosppsych.2023.01.014. Epub 2023 Feb 3.
9
Functional decline in hospitalized older patients with coronavirus disease 2019: a retrospective cohort study.COVID-19 住院老年患者的功能衰退:一项回顾性队列研究。
BMC Geriatr. 2021 Nov 12;21(1):638. doi: 10.1186/s12877-021-02597-w.
10
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.

引用本文的文献

1
COVID-19 inpatient care performance in the unified health system, São Paulo state, Brazil: an application of standardized mortality ratio for hospitals' comparisons : COVID-19 inpatient care performance in SUS, Brazil.巴西圣保罗州统一卫生系统中 COVID-19 住院患者护理绩效的评估:应用标准化死亡率对医院进行比较:巴西 SUS 中的 COVID-19 住院患者护理绩效。
BMC Health Serv Res. 2024 Sep 27;24(1):1125. doi: 10.1186/s12913-024-11496-w.
2
Acute and chronic kidney disease and risk of hospital mortality during COVID-19 pandemic waves in the pre-vaccination era.疫苗接种前时代新冠疫情各波期间急性和慢性肾脏病与医院死亡风险
Clin Kidney J. 2022 Oct 28;16(2):374-383. doi: 10.1093/ckj/sfac239. eCollection 2023 Feb.
3

本文引用的文献

1
Increased Transmissibility of the SARS-CoV-2 Alpha Variant in a Japanese Population.在日本人群中,SARS-CoV-2 阿尔法变异株的传染性增强。
Int J Environ Res Public Health. 2021 Jul 22;18(15):7752. doi: 10.3390/ijerph18157752.
2
Trends in COVID-19 case-fatality rates in Brazilian public hospitals: A longitudinal cohort of 398,063 hospital admissions from 1st March to 3rd October 2020.2020 年 3 月 1 日至 10 月 3 日巴西公立医院 COVID-19 病死率趋势:一项对 398,063 例住院患者的纵向队列研究。
PLoS One. 2021 Jul 16;16(7):e0254633. doi: 10.1371/journal.pone.0254633. eCollection 2021.
3
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK.
Changing trends of patient characteristics and treatment pathways during the COVID-19 pandemic: A cross-sectional analysis of 72,459 inpatient cases from the German Helios database.
在 COVID-19 大流行期间患者特征和治疗途径的变化趋势:来自德国 Helios 数据库的 72459 例住院患者的横断面分析。
Front Public Health. 2022 Nov 7;10:1028062. doi: 10.3389/fpubh.2022.1028062. eCollection 2022.
COVID-19 第一波疫情期间住院死亡率的变化:使用世卫组织临床特征化方案 UK 的多中心前瞻性观察队列研究。
Lancet Respir Med. 2021 Jul;9(7):773-785. doi: 10.1016/S2213-2600(21)00175-2. Epub 2021 May 14.
4
Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic.美国在 COVID-19 大流行期间患者特征和 COVID-19 院内死亡率的趋势。
JAMA Netw Open. 2021 May 3;4(5):e218828. doi: 10.1001/jamanetworkopen.2021.8828.
5
Clinical characteristics of Japanese patients with moderate to severe COVID-19.伴有中重度 COVID-19 的日本患者的临床特征。
J Infect Chemother. 2021 Jun;27(6):895-901. doi: 10.1016/j.jiac.2021.02.028. Epub 2021 Mar 4.
6
Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data.英格兰 COVID-19 住院患者病死率的相关患者因素和时间趋势:基于行政数据的观察性研究。
Lancet Respir Med. 2021 Apr;9(4):397-406. doi: 10.1016/S2213-2600(20)30579-8. Epub 2021 Feb 15.
7
First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics.日本的第一波和第二波新冠疫情:疾病严重程度和特征的比较。
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.10.033. Epub 2020 Nov 2.
8
Trends in COVID-19 Risk-Adjusted Mortality Rates.COVID-19 风险调整死亡率趋势。
J Hosp Med. 2021 Feb;16(2):90-92. doi: 10.12788/jhm.3552.
9
Association of SARS-CoV-2 Genomic Load with Outcomes in Patients with COVID-19.严重急性呼吸综合征冠状病毒2基因组载量与新型冠状病毒肺炎患者预后的关联
Ann Am Thorac Soc. 2021 May;18(5):900-903. doi: 10.1513/AnnalsATS.202008-931RL.
10
Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine.新冠疫情下的面部遮盖——在等待疫苗期间“人痘接种”的可能性。
N Engl J Med. 2020 Oct 29;383(18):e101. doi: 10.1056/NEJMp2026913. Epub 2020 Sep 8.